Evidence map›Paper›PMID 29305946›Full record

Trial reportMetabolism: clinical and experimental2018

A whole-grain diet reduces peripheral insulin resistance and improves glucose kinetics in obese adults: A randomized-controlled trial.

Steven K Malin, Emily L Kullman, Amanda R Scelsi, Jacob M Haus, Julianne Filion, Mangesh R Pagadala, Jean-Philippe Godin, Sunil Kochhar, Alastair B Ross, John P Kirwan

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Metabolism: clinical and experimental, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Steven K MalinDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Emily L KullmanDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Amanda R ScelsiDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Jacob M HausDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Julianne FilionDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Mangesh R PagadalaDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Jean-Philippe GodinAnalytical Sciences Department, Nestlé Research Center, Lausanne, Switzerland.
Sunil KochharAnalytical Sciences Department, Nestlé Research Center, Lausanne, Switzerland.
Alastair B RossAnalytical Sciences Department, Nestlé Research Center, Lausanne, Switzerland.
John P KirwanDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States; Metabolic Research Center, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address: kirwanj@ccf.org.

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
TRAINING IN METABOLISMT32DK007319 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BRUNENGRABER, HENRI · 1986 to 2013
$5.0M
NCATS NIH HHS UL1 TR000439NCRR NIH HHS UL1 RR024989NIDDK NIH HHS P30 DK020572NIDDK NIH HHS T32 DK007319
6 · The paper itself

Abstract

backgroundWhole-grain intake is associated with lower risk of type 2 diabetes but the mechanisms are unclear. PURPOSE: We tested the hypothesis that a WG diet reduces insulin resistance and improves glucose use in individuals at risk for type 2 diabetes compared with an isocaloric-matched refined-grain diet.

methodsA double-blind, randomized, controlled, crossover trial of 14 moderately obese adults (Age, 38 ± 2 y; BMI, 34.0 ± 1.1 kg/m

resultsPost-prandial glucose tolerance, peripheral insulin sensitivity, and metabolic flexibility (insulin-stimulated - fasting carbohydrate oxidation) improvements were greater after whole-grain compared to the refined-grain diet (P < 0.05). Compared to baseline, body fat (~2 kg) and hepatic R

conclusionWhole-grains reduced diabetes risk and the mechanisms appear to work through reduced post-prandial blood glucose and peripheral insulin resistance that were statistically linked to enhanced metabolic flexibility.

Indexed as

Whole GrainsAdultBlood GlucoseCross-Over StudiesDietary FiberDouble-Blind MethodFemaleGlucoseHumansInsulin ResistanceMaleObesityTreatment OutcomeBlood GlucoseDietary FiberGlucoseAlkylresorcinolsGlucose toleranceInsulinLow-glycemic dietObesity

Identifiers

PMID29305946
PMCPMC5930046

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.